Acquired adaptive immune cell dysfunction and restoration in chronic hepatitis B
This project aims to uncover and reprogram dysfunctional adaptive immune cells in chronic hepatitis B infection using advanced imaging and analysis techniques to enhance antiviral responses.
Projectdetails
Introduction
This proposal aims to investigate the development of dysfunctional adaptive immune cells during chronic hepatitis B virus (HBV) infection and to develop new strategies to reprogram them into functional cells with potent antiviral activity. Our hypothesis, based on extensive preliminary data, is that HBV induces a unique type of adaptive immune cell dysfunction that differs from that observed in other viral infections or cancer.
Research Methodology
To investigate this, we will use unique mouse models of HBV pathogenesis, several of which have been generated ad hoc for this proposal, and well-characterized patient cohorts to identify, dissect, and target dysregulated pathways that cause adaptive immune cell dysfunction during chronic hepatitis B.
Imaging Techniques
State-of-the-art static and dynamic imaging will be employed to analyze the behavior of adaptive immune cells that ultimately differentiate into dysfunctional cells in the liver at unprecedented levels of spatial and temporal resolution.
Flow Cytometry and Sequencing
In parallel, high-dimensional flow cytometry and single-cell sequencing in mouse models of HBV pathogenesis and in chronically infected patients will reveal the underlying proteogenomic landscape and heterogeneity that cause adaptive immune cell dysfunction.
Targeting Immunoregulatory Mechanisms
Finally, immunoregulatory mechanisms already identified in preliminary work or that will emerge from the above analyses will be targeted both in vitro and in vivo.
Conclusion
By studying all the main players of HBV immunity together with state-of-the-art techniques and by interconnecting research with mouse models and analyses of human samples, we are in a unique position to make fundamental leaps in our understanding of adaptive immunity and viral pathogenesis.
We are confident that the results emerging from this proposal will have the potential to guide the design of novel, rational strategies to direct the immune system to terminate chronic HBV infection and its associated costs and complications.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.500.000 |
Totale projectbegroting | € 2.500.000 |
Tijdlijn
Startdatum | 1-9-2024 |
Einddatum | 31-8-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- UNIVERSITA VITA-SALUTE SAN RAFFAELEpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Interplay of CMV with cellular pathways, states and cell typesThis project aims to develop advanced tools to investigate HCMV-host interactions, uncover viral protein functions, and identify infection vulnerabilities to enhance therapeutic strategies. | ERC Consolid... | € 2.000.000 | 2025 | Details |
Function of Cholangiocytes in chronic liver diseasesThis project aims to investigate cholangiocyte mechanisms in chronic liver disease using organoids and animal models to develop therapies for tissue repair and cancer prevention. | ERC Advanced... | € 2.499.289 | 2025 | Details |
What does your blood remember? The memory of hematopoietic stem cells.This project aims to investigate how hematopoietic stem cells develop adaptive memory to environmental stress, enhancing blood cell responses and improving transplantation strategies. | ERC Starting... | € 2.500.000 | 2022 | Details |
Dynamics and heterogeneity of early viral infectionThis project aims to enhance imaging technology to study early infection processes of negative-sense RNA viruses, focusing on RSV to understand viral propagation and inform therapeutic strategies. | ERC Consolid... | € 2.000.000 | 2023 | Details |
Reversing vaccine hypo-responsivenessThe project aims to understand and reverse vaccine hypo-responsiveness across populations by investigating immunological and metabolic factors, ultimately improving vaccine efficacy globally. | ERC Advanced... | € 2.372.681 | 2022 | Details |
Interplay of CMV with cellular pathways, states and cell types
This project aims to develop advanced tools to investigate HCMV-host interactions, uncover viral protein functions, and identify infection vulnerabilities to enhance therapeutic strategies.
Function of Cholangiocytes in chronic liver diseases
This project aims to investigate cholangiocyte mechanisms in chronic liver disease using organoids and animal models to develop therapies for tissue repair and cancer prevention.
What does your blood remember? The memory of hematopoietic stem cells.
This project aims to investigate how hematopoietic stem cells develop adaptive memory to environmental stress, enhancing blood cell responses and improving transplantation strategies.
Dynamics and heterogeneity of early viral infection
This project aims to enhance imaging technology to study early infection processes of negative-sense RNA viruses, focusing on RSV to understand viral propagation and inform therapeutic strategies.
Reversing vaccine hypo-responsiveness
The project aims to understand and reverse vaccine hypo-responsiveness across populations by investigating immunological and metabolic factors, ultimately improving vaccine efficacy globally.